Synergistic effects of exosomal crocin or curcumin compounds and HPV L1-E7 polypeptide vaccine construct on tumor eradication in C57BL/6 mouse model
Authors:
Open Access
- 14 October 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (10) , e0258599
Abstract
Cervical cancer is the most common malignant tumor in females worldwide. Human papillomavirus (HPV) infection is associated with the occurrence of cervical cancer. Thus, developing an effective and low-cost vaccine against HPV infection, especially in developing countries is an important issue. In this study, a novel HPV L1-E7 fusion multiepitope construct designed by immunoinformatics tools was expressed in bacterial system. HEK-293T cells-derived exosomes were generated and characterized to use as a carrier for crocin and curcumin compounds. The exosomes loaded with crocin and curcumin compounds as a chemotherapeutic agent (ExoCrocin and ExoCurcumin) were used along with the L1-E7 polypeptide for evaluation of immunological and anti-tumor effects in C57BL/6 mouse model.In vitrostudies showed that ExoCrocin and ExoCurcumin were not cytotoxic at a certain dose, and they could enter tumor cells.In vivostudies indicated that combination of the L1-E7 polypeptide with ExoCrocin or ExoCurcumin could produce a significant level of immunity directed toward Th1 response and CTL activity. These regimens showed the protective and therapeutic effects against tumor cells (the percentage of tumor-free mice: ~100%). In addition, both ExoCrocin and ExoCurcumin represented similar immunological and anti-tumor effects. Generally, the use of exosomal crocin or curcumin forms along with the L1-E7 polypeptide could significantly induce T-cell immune responses and eradicate tumor cells.Keywords
This publication has 54 references indexed in Scilit:
- A new method for pH triggered curcumin release by applying poly(l-lysine) mediated nanoparticle-congregationAnalytica Chimica Acta, 2013
- Improvement of cytotoxic and apoptogenic properties of crocin in cancer cell lines by its nanoliposomal formPharmaceutical Biology, 2011
- A Novel Nanoparticle Drug Delivery System: The Anti-inflammatory Activity of Curcumin Is Enhanced When Encapsulated in ExosomesMolecular Therapy, 2010
- Preventive Effect of Crocin in Inflamed Animals and in LPS-Challenged RAW 264.7 CellsJournal of Agricultural and Food Chemistry, 2009
- High Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma PatientsPLOS ONE, 2009
- Interaction of Saffron Carotenoids as Anticancer Compounds with ctDNA, Oligo (dG.dC) 15 , and Oligo (dA.dT) 15DNA and Cell Biology, 2007
- The Role of Toll-Like Receptors in the Regulation of Neutrophil Migration, Activation, and ApoptosisClinical Infectious Diseases, 2005
- Liposome‐encapsulated curcuminCancer, 2005
- A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancerThe Lancet, 1996
- Crocin, safranal and picrocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitroCancer Letters, 1996